Healixa Announces Appointment of Two Additional Independent Directors
Healixa Prepares
Announces Appointment of Two Additional Independent
Directors
Expansion fulfills Board
governance guidelines for national
exchanges
New York, New York -- June 14,
2022 -- InvestorsHub NewsWire -- Healixa,
Inc. (OTC:
EMOR) ("Healixa," or the "Company"), a technology company
focusing on building and acquiring innovative and disruptive
technologies in the health-tech, clean water, and green-tech
industries, today announced that it has expanded its Board of
Directors with the appointment of Fig Annunziato and Dong Yun
(“Kevin”) Kim as independent directors.
“We are pleased to welcome Fig and
Kevin to our Board as we make final prepare to apply for a
potential uplisting to a national exchange,” commented Ian Parker,
Chairman and CEO of Healixa. “Healixa is striving to meet the
highest standards of corporate governance, and with the addition of
Fig and Kevin, the majority of our Board is now held by independent
directors. These latest accomplished executives to join our board
bring extensive financial, operational, and market experience, and
we look forward to benefiting from their diverse backgrounds and
respective expertise, which we believe will prove indispensable as
we enter a critical period of accelerating growth.”
Fig Annuziato currently serves as
Chief Executive Officer at ClaimFox, an expert in claim file
request fulfillment. She has set the standard for excellence in
client service and data management solutions at ClaimFox. Fig is
responsible for ClaimFox's strategic direction, leads new business
development, and oversees several national and regional accounts.
Before ClaimFox, Fig worked for the U.S. Government, handling
strategic issues at the Government Accountability Office (GAO) -
the investigative arm of the U.S. Congress charged with examining
matters relating to the receipt and payment of public
funds.
Kevin Kim currently serves as Chief
Revenue Officer for KEB Hana Bank, N.A., where he manages overall
lending activities of the business banking team, including SBA
Loans, CRE Loans, and C&I loans. Kevin’s experience in
reviewing and interpreting GAAP financial statements and ensuring
credits are underwritten properly before final loan add an
important perspective to the oversight of Healixa.
About Healixa,
Inc.
Healixa is a technology company
focusing on building and acquiring innovative and disruptive
technologies in the health-tech, clean water generation and
green-tech industries. Healixa embraces innovation by combining its
intellectual properties, patents, strategic collaborations, and
partnerships to create disruptive, sustainable products. For more
information, visit www.healixa.com.
Safe Harbor
Statement
Certain statements contained in this
press release may constitute forward-looking statements. For
example, forward-looking statements are used when discussing our
expected research and development programs, and more. These
forward-looking statements are based only on current expectations
of management and are subject to significant risks and
uncertainties that could cause actual results to differ materially
from those described in the forward-looking statements, including
but not limited to the risks and uncertainties related to the
progress, timing, cost, and results of Partnerships and product
development programs; difficulties or delays in obtaining
regulatory approval or patent protection; and competition from
other companies. Except as otherwise required by law, Healixa, Inc.
undertakes no obligation to publicly release any revisions to these
forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrence of unanticipated
events.
Healixia
Contact:
Bret Hedges
SVP of Strategic
Partnerships
833-432-5492
Bret@healixa.com
Scott Powell, Advisor
Office: 646-893-5835
Healixa (PK) (USOTC:EMOR)
過去 株価チャート
から 11 2024 まで 12 2024
Healixa (PK) (USOTC:EMOR)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Healixa Inc (PK) (その他OTC): 0 recent articles
その他のHealixa Inc (PK)ニュース記事